Efficacy and Safety of Hydroxychloroquine in the Treatment of Sudden Sensorineural Hearing Loss | MicrobiomeTrials← Back to trialsNCT06467526
Efficacy and Safety of Hydroxychloroquine in the Treatment of Sudden Sensorineural Hearing Loss
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2024-09-10Est. Completion: 2026-12-31
Enrollment target: 80 participants Locations- Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan
Other microbiome trials you might be interested in
Sudden Sensorineural Hearing Loss (SSNHL)
Total-type sudden sensorineural hearing loss (defined in this study as severe-to-profound sudden sensorineural hearing l…
Guangzhou, ChinaEst. completion Sep 30, 2029
Meniere's DiseaseMeniere DiseaseMeniere´s DiseaseMeniere's Disease AggravatedSudden Sensorineural Hearing LossSudden Sensorineural Hearing Loss (SSNHL)
The purpose of this protocol is to facilitate expanded access ("compassionate use") of SPI-1005 to Meniere's disease (MD…
Multiple Locations